Draft guidance on approval of clinical trials and new drugs

  This guidance documents has been prepared to specify the general requirements for approval of clinical trial and different categories of New Drugs viz. Investigational New Drugs, New drugs substances, additional strength, additional indication, modified release...

‘Medicines for All’, the Pharma Industry and the Indian State

‘Medicines for All’, the Pharma Industry and the Indian State S Srinivasan Economic & Political Weekly EPW June 11, 2011 vol xlvi no 24 When we consider that expenditure on medicines in India accounts for 50% to 80% of treatment costs, India’s pharmaceutical...